https://gpcardio.org/en/
https://gpcardio.org/en/2014-05-28_practical-guidance-for-primary-care-physicians-on-statin-use-in-people-at-risk-of-getting-diabetes/
https://gpcardio.org/en/2015-01-07_the-epccs-stroke-prevention-in-atrial-fibrillation-guidance-document-1/
https://gpcardio.org/en/2015-09-29_lively-debate-at-annual-epccs-clinical-masterclass-to-yield-practical-guidance/
https://gpcardio.org/en/2015-10-02_what-s-the-evidence-base-for-blood-pressure-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-02_what-s-the-evidence-base-for-health-behaviour-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-12_what-s-the-evidence-base-for-lipid-modification-in-the-guideline-updates/
https://gpcardio.org/en/2015-10-14_what-s-the-evidence-base-for-heart-failure-diagnosis-and-management-in-the-guideline-updates/
https://gpcardio.org/en/2016-03-15_what-is-the-evidence-base-for-lipid-modification-in-the-guidelines-updates/
https://gpcardio.org/en/2016-04-15_identifying-and-treating-patients-with-true-hypertension/
https://gpcardio.org/en/2016-05-26_the-evidence-base-for-health-behaviour-changes/
https://gpcardio.org/en/2016-09-06_epccs-consensus-guidance-on-stroke-prevention-in-atrial-fibrillation-spaf-in-primary-care/
https://gpcardio.org/en/2016-09-28_epccs-guidance-documents/
https://gpcardio.org/en/2017-03-30_guidance-on-changing-health-behaviours-what-is-the-evidence-what-s-recommended-and-do-i-agree/
https://gpcardio.org/en/2017-04-20_atrial-fibrillation-management-what-do-the-guidelines-say-and-what-are-the-implications-for-primary-care/
https://gpcardio.org/en/2017-04-20_controversies-in-hypertension-what-are-the-implication-of-sprint-in-the-context-of-recent-treatment-trials/
https://gpcardio.org/en/2017-04-20_controversies-in-lipids-is-the-role-of-statins-now-clear-are-there-alternatives-and-what-s-in-the-pipeline/
https://gpcardio.org/en/2017-04-20_guidance-on-changing-health-behaviours-what-is-the-evidence-what-s-recommended-and-do-i-agree/
https://gpcardio.org/en/2017-04-20_lipid-management-what-do-the-guidelines-say-and-what-are-the-implications-for-primary-care/
https://gpcardio.org/en/2017-04-20_what-s-the-new-evidence-base-for-heart-failure-diagnosis-management/
https://gpcardio.org/en/2017-06-05_ingredients-of-effective-strategies-to-stimulate-behaviour-change/
https://gpcardio.org/en/2017-06-22_how-do-the-latest-guideline-changes-affect-management-of-dyslipidaemia-in-primary-care/
https://gpcardio.org/en/2017-07-01_epccs-heart-failure-guidance-published-as-clinical-intelligence-in-br-j-gen-prac/
https://gpcardio.org/en/2017-07-18_heart-failure-diagnosis-and-management-varies-substantially-across-european-countries/
https://gpcardio.org/en/2017-09-13_what-can-be-learned-from-the-latest-hypertension-trials/
https://gpcardio.org/en/2017-12-10_epccs-practical-guidance-on-heart-failure-diagnosis-and-management-in-primary-care/
https://gpcardio.org/en/2018-02-06_how-can-epccs-expand-its-membership/
https://gpcardio.org/en/2018-02-06_how-can-the-epccs-better-engage-with-primary-care-physicians-in-various-european-countries-regarding-cardiovascular-disease-education/
https://gpcardio.org/en/2018-02-19_chronicke-srdcove-zlyhavanie/
https://gpcardio.org/en/2018-02-19_prevencia-cievnej-mozgovej-prihody-u-pacientov-s-fibrilaciou-predsieni/
https://gpcardio.org/en/2018-02-19_практична-настанова-по-діагностиці-та-менеджменту-серцевої-недостатності-в-системі-первинної-медичної-допомоги/
https://gpcardio.org/en/2018-02-22_stimulating-health-behaviour-changes-to-reduce-cardiovascular-risk-in-primary-care/
https://gpcardio.org/en/2018-02-25_slides-organisation-of-primary-care-in-the-netherlands/
https://gpcardio.org/en/2018-02-26_netherlands-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-26_slides-organisation-of-primary-care-in-slovakia/
https://gpcardio.org/en/2018-02-26_slides-primary-care-in-bulgaria-nagpb/
https://gpcardio.org/en/2018-02-26_slovakia-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-27_slides-cardiovascular-primary-care-in-spain/
https://gpcardio.org/en/2018-02-27_slides-organisation-of-primary-care-in-portugal/
https://gpcardio.org/en/2018-02-28_bulgaria-cardiovascular-primary-care/
https://gpcardio.org/en/2018-02-28_portugal-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-02-28_slides-cardiovascular-primary-care-in-france/
https://gpcardio.org/en/2018-02-28_spain-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_france-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_greece-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_romania-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-01_slides-cardiovascular-primary-care-in-greece/
https://gpcardio.org/en/2018-03-01_slides-cardiovascular-primary-care-in-romania/
https://gpcardio.org/en/2018-03-02_germany-cardiovascular-primary-care-overview/
https://gpcardio.org/en/2018-03-02_slides-cardiovascular-primary-care-in-germany/
https://gpcardio.org/en/2018-03-13_погоджена-настанова-epccs-щодо-профілактики-інсульту-при-фібриляції-передсердь-в-системі-надання-первинної-медичної-допомоги/
https://gpcardio.org/en/2018-03-27_lower-extremity-artery-disease-a-neglected-major-cv-disease/
https://gpcardio.org/en/2018-03-27_stimularea-schimbarilor-de-comportament-in-domeniul-sanatatii-pentru-a-reduce-riscul-cardiovascular-in-asistenta-medicala-primara/
https://gpcardio.org/en/2018-03-28_diabetes-and-vascular-disease-epidemiology-and-management-options/
https://gpcardio.org/en/2018-04-04_managing-elevated-lipids-and-statins-the-good-the-bad-and-the-ugly/
https://gpcardio.org/en/2018-04-04_slides-hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-04-04_slides-lipid-lowering-the-evidence-the-guidelines-the-clinical-reality/
https://gpcardio.org/en/2018-04-04_slides-lower-extremity-artery-disease-a-neglected-major-cv-disease-diagnose-and-clinical-management-in-primary-care/
https://gpcardio.org/en/2018-04-04_slides-managing-complex-heart-failure-a-specialist-view-of-the-primary-secondary-interface/
https://gpcardio.org/en/2018-04-04_slides-managing-heart-failure-in-primary-care-the-gp-perspective/
https://gpcardio.org/en/2018-04-04_slides-practical-workshop-on-abpm/
https://gpcardio.org/en/2018-04-04_slides-type-2-diabetes-cardiovascular-disease-update/
https://gpcardio.org/en/2018-04-10_complexities-of-managing-heart-failure-in-primary-care/
https://gpcardio.org/en/2018-04-10_hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-04-24_management-of-cv-risk-that-comes-with-t2dm-in-light-of-novel-treatment-options/
https://gpcardio.org/en/2018-05-16_cardiovascular-primary-care-in-italy/
https://gpcardio.org/en/2018-05-16_slides-primary-care-in-italy/
https://gpcardio.org/en/2018-05-22_lipid-lowering-the-evidence-the-guidelines-the-clinical-reality/
https://gpcardio.org/en/2018-06-15_semergen-la-sociedad-decana-de-la-medicina-de-familia-en-espana/
https://gpcardio.org/en/2018-06-15_semergen-sociedad-espanola-de-medicos-de-atencion-primaria/
https://gpcardio.org/en/2018-06-19_spain-epccs-introduction/
https://gpcardio.org/en/2018-07-18_complexities-of-managing-heart-failure/
https://gpcardio.org/en/2018-08-16_hypertension-can-we-agree-on-diagnostic-and-therapeutic-thresholds/
https://gpcardio.org/en/2018-08-22_managing-elevated-lipids-in-primary-care/
https://gpcardio.org/en/2018-10-22_general-practitioner-in-denmark/
https://gpcardio.org/en/2018-10-22_managementul-dislipidemiei-in-asistenta-medicala-primara/
https://gpcardio.org/en/2018-10-22_praktican-vodic-za-dijagnostikovanje-i-lecenje-srcane-insuficijencije-u-primarnoj-zdravstvenoj-zastiti-pzz/
https://gpcardio.org/en/2018-10-22_stimulacija-promene-zivotnog-stila-u-cilju-smanjenja-kardiovaskularnog-rizika-u-pzz/
https://gpcardio.org/en/2018-10-23_prevention-of-cardiovascular-noncommunicable-disease-in-primary-care-in-russia/
https://gpcardio.org/en/2018-10-25_lecenje-povisenih-lipida-u-primarnoj-zdravstvenoj-zastiti-pzz/
https://gpcardio.org/en/2018-10-30_шляхи-стимулювання-модифікації-способу-життя-з-метою-зменшення-серцево-судинного-ризику-на-первинній-ланці-медичної-допомоги/
https://gpcardio.org/en/2018-12-03_primary-cardiovascular-care-in-serbia-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-czech-republic-czech/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-czech-republic-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-montenegro-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-serbia-serbian/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-ukraine-english/
https://gpcardio.org/en/2018-12-04_primary-cardiovascular-care-in-ukraine-ukrainian/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-belgium-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-belgium-flemish/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-poland-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-poland-polish/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-slovakia-english/
https://gpcardio.org/en/2018-12-05_primary-cardiovascular-care-in-slovakia-slovak/
https://gpcardio.org/en/2018-12-07_primary-cardiovascular-care-in-germany-english/
https://gpcardio.org/en/2018-12-07_primary-cardiovascular-care-in-germany-german/
https://gpcardio.org/en/2018-12-10_primary-cardiovascular-care-in-ireland-english/
https://gpcardio.org/en/2018-12-10_primary-cardiovascular-care-in-turkey-turkish/
https://gpcardio.org/en/2018-12-13_primary-cardiovascular-care-in-turkey-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-denmark-danish/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-denmark-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-montenegro-montenegrin/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-romania-romanian/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-spain-english/
https://gpcardio.org/en/2018-12-17_primary-cardiovascular-care-in-spain-spanish/
https://gpcardio.org/en/2018-12-18_slides-take-home-messages-of-epccs-guidance-on-managing-elevated-lipids-in-primary-care/
https://gpcardio.org/en/2019-01-10_primary-cardiovascular-care-in-spain-english/
https://gpcardio.org/en/2019-01-10_primary-cardiovascular-care-in-spain-spanish/
https://gpcardio.org/en/2019-02-07_epccs-society-what-is-available-for-members/
https://gpcardio.org/en/2019-02-25_current-management-of-diabetes-and-cardiovascular-risk-in-primary-care/
https://gpcardio.org/en/2019-03-28_diabetes-and-cardiovascular-risk/
https://gpcardio.org/en/2019-03-28_how-to-deal-with-the-challenges-of-multimorbidity-in-general-practice/
https://gpcardio.org/en/2019-03-28_update-on-stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-02_slides-complexities-of-managing-heart-failure/
https://gpcardio.org/en/2019-04-02_slides-cvd-and-mental-health/
https://gpcardio.org/en/2019-04-02_slides-diabetes-and-cardiovascular-risk/
https://gpcardio.org/en/2019-04-02_slides-multimorbidity-cv-disease-and-polypharmacy/
https://gpcardio.org/en/2019-04-02_slides-recent-updates-to-the-international-hypertension-guidelines-where-do-they-vary-and-what-should-we-agree-in-primary-care/
https://gpcardio.org/en/2019-04-02_slides-update-on-stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-02_slides-what-s-the-evidence-that-diabetes-is-linked-to-cvd-risk/
https://gpcardio.org/en/2019-04-03_complexities-of-managing-heart-failure/
https://gpcardio.org/en/2019-04-09_sham-controlled-randomized-trials-of-catheter-based-renal-denervation-in-patients-with-hypertension/
https://gpcardio.org/en/2019-04-11_coronary-angiography-after-cardiac-arrest-without-st-segment-elevation/
https://gpcardio.org/en/2019-04-18_antithrombotic-therapy-after-acute-coronary-syndrome-or-pci-in-atrial-fibrillation/
https://gpcardio.org/en/2019-04-18_early-or-delayed-cardioversion-in-recent-onset-atrial-fibrillation/
https://gpcardio.org/en/2019-04-23_comparison-of-the-effects-of-glucagon-like-peptide-receptor-agonists-and-sodium-glucose-cotransporter-2-inhibitors-for-prevention-of-major-adverse-car/
https://gpcardio.org/en/2019-04-24_recent-updates-to-the-international-hypertension-guidelines-where-do-they-vary-and-what-should-we-agree-in-primary-care/
https://gpcardio.org/en/2019-04-25_a-fully-magnetically-levitated-left-ventricular-assist-device-final-report/
https://gpcardio.org/en/2019-04-25_education-exchange-guidance-and-interaction-during-epccs-summit-2019/
https://gpcardio.org/en/2019-05-02_slides-managing-diabetes-in-daily-cardiovascular-practice-a-multidisciplinary-approach/
https://gpcardio.org/en/2019-05-02_slides-targeting-cvd-in-diabetes-novel-strategies-to-tackle-the-risk/
https://gpcardio.org/en/2019-05-02_slides-type-2-diabetes-cv-outcomes-more-than-glucose-management-lessons-from-glp1-ra-trials/
https://gpcardio.org/en/2019-05-02_transcatheter-aortic-valve-replacement-with-a-balloon-expandable-valve-in-low-risk-patients/
https://gpcardio.org/en/2019-05-02_transcatheter-aortic-valve-replacement-with-a-self-expanding-valve-in-low-risk-patients/
https://gpcardio.org/en/2019-05-07_stroke-prevention-in-atrial-fibrillation/
https://gpcardio.org/en/2019-05-21_update-on-managing-cv-risk-in-diabetes-what-s-the-evidence/
https://gpcardio.org/en/2019-05-28_dapagliflozin-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-mellitus-and-previous-myocardial-infarction/
https://gpcardio.org/en/2019-05-28_effect-of-dapagliflozin-on-heart-failure-and-mortality-in-type-2-diabetes-mellitus/
https://gpcardio.org/en/2019-06-11_effects-of-icosapent-ethyl-on-total-ischemic-events/
https://gpcardio.org/en/2019-06-13_canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/
https://gpcardio.org/en/2019-06-18_2018-aha-acc-aacvpr-aapa-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-blood-cholesterol/
https://gpcardio.org/en/2019-06-18_2018-aha-acc-aacvpr-aapa-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-blood-cholesterol/
https://gpcardio.org/en/2019-06-18_new-diagnostic-algorithm-and-therapeutic-options-in-hf-management/
https://gpcardio.org/en/2019-06-18_systematic-review-for-the-2018-aha-acc-aacvpr-aapa-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-blood-cholesterol/
https://gpcardio.org/en/2019-06-20_comparison-of-dual-therapies-for-lowering-blood-pressure-in-black-africans/
https://gpcardio.org/en/2019-06-22_drug-eluting-or-bare-metal-stents-for-percutaneous-coronary-intervention/
https://gpcardio.org/en/2019-06-25_2018-aha-acc-aacvpr-aapa-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-blood-cholesterol/
https://gpcardio.org/en/2019-06-25_2018-aha-acc-aacvpr-aapa-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-blood-cholesterol/
https://gpcardio.org/en/2019-06-25_effect-of-1-month-dual-antiplatelet-therapy-followed-by-clopidogrel-vs-12-month-dual-antiplatelet-therapy-on-cardiovascular-and-bleeding-events-in-pat/
https://gpcardio.org/en/2019-06-25_effect-of-p2y12-inhibitor-monotherapy-vs-dual-antiplatelet-therapy-on-cardiovascular-events-in-patients-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2019-06-25_systematic-review-for-the-2018-aha-acc-aacvpr-aapa-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-blood-cholesterol/
https://gpcardio.org/en/2019-07-09_2019-aha-acc-hrs-focused-update-of-the-2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2019-07-09_effect-of-alirocumab-on-mortality-after-acute-coronary-syndromes/
https://gpcardio.org/en/2019-07-13_dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind/
https://gpcardio.org/en/2019-08-08_volanesorsen-and-triglyceride-levels-in-familial-chylomicronemia-syndrome/
https://gpcardio.org/en/2019-08-13_association-of-intensive-vs-standard-blood-pressure-control-with-cerebral-white-matter-lesions/
https://gpcardio.org/en/2019-08-13_slides-take-home-messages-of-epccs-guidance-on-current-management-of-diabetes-and-cv-risk-in-primary-care/
https://gpcardio.org/en/2019-08-20_2018-acc-aha-hrs-guideline-on-the-evaluation-and-management-of-patients-with-bradycardia-and-cardiac-conduction-delay/
https://gpcardio.org/en/2019-08-22_effects-of-serelaxin-in-patients-with-acute-heart-failure/
https://gpcardio.org/en/2019-08-24_effectiveness-of-polypill-for-primary-and-secondary-prevention-of-cardiovascular-diseases-polyiran/
https://gpcardio.org/en/2019-08-24_long-term-and-recent-trends-in-hypertension-awareness-treatment-and-control-in-12-high-income-countries/
https://gpcardio.org/en/2019-08-24_the-state-of-hypertension-care-in-44-low-income-and-middle-income-countries/
https://gpcardio.org/en/2019-08-29_diagnosis-and-management-of-hypertension-in-primary-care/
https://gpcardio.org/en/2019-08-29_oral-semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2019-09-19_antithrombotic-therapy-for-atrial-fibrillation-with-stable-coronary-disease/
https://gpcardio.org/en/2019-09-19_polypill-for-cardiovascular-disease-prevention-in-an-underserved-population/
https://gpcardio.org/en/2019-09-28_ticagrelor-in-patients-with-diabetes-and-stable-coronary-artery-disease-with-a-history-of-previous-percutaneous-coronary-intervention-themis-pci/
https://gpcardio.org/en/2019-10-02_outreach-of-epccs-into-european-countries-what-s-in-store/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-serbia/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-slovakia-english/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-slovakia-slovak/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-spain-english/
https://gpcardio.org/en/2019-10-03_epccs-and-primary-cv-care-in-spain-spanish/
https://gpcardio.org/en/2019-10-03_how-epccs-aims-to-help-primary-care-physicians-across-europe-in-recognizing-and-managing-cv-risk-greek/
https://gpcardio.org/en/2019-10-03_ticagrelor-in-patients-with-stable-coronary-disease-and-diabetes/
https://gpcardio.org/en/2019-10-09_how-epccs-aims-to-help-primary-care-physicians-across-europe-in-recognizing-and-managing-cv-risk-english/
https://gpcardio.org/en/2019-10-10_complete-revascularization-with-multivessel-pci-for-myocardial-infarction/
https://gpcardio.org/en/2019-10-12_edoxaban-based-versus-vitamin-k-antagonist-based-antithrombotic-regimen-after-successful-coronary-stenting-in-patients-with-atrial-fibrillation-entrus/
https://gpcardio.org/en/2019-10-12_percutaneous-coronary-intervention-versus-coronary-artery-bypass-grafting-in-patients-with-three-vessel-or-left-main-coronary-artery-disease/
https://gpcardio.org/en/2019-10-15_association-between-triglyceride-lowering-and-reduction-of-cardiovascular-risk-across-multiple-lipid-lowering-therapeutic-classes/
https://gpcardio.org/en/2019-10-17_ticagrelor-or-prasugrel-in-patients-with-acute-coronary-syndromes/
https://gpcardio.org/en/2019-10-19_effect-of-remote-ischaemic-conditioning-on-clinical-outcomes-in-patients-with-acute-myocardial-infarction-condi-2-eric-ppci/
https://gpcardio.org/en/2019-10-24_a-genotype-guided-strategy-for-oral-p2y12-inhibitors-in-primary-pci/
https://gpcardio.org/en/2019-10-24_angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2019-10-26_patiromer-versus-placebo-to-enable-spironolactone-use-in-patients-with-resistant-hypertension-and-chronic-kidney-disease-amber/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-french-abstract/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-greek-abstract/
https://gpcardio.org/en/2019-10-29_diagnosis-and-management-of-hypertension-in-primary-care-ukrainian-abstract/
https://gpcardio.org/en/2019-10-29_dijagnostikovanje-i-lecenje-hipertenzije-u-primarnoj-zdravstvenoj-zastiti-serbian-abstract-of-epccs-guidance-on-hypertension/
https://gpcardio.org/en/2019-10-29_french-society-of-general-medicine-sfmg/
https://gpcardio.org/en/2019-10-29_greek-societies-involved-in-primary-care/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-france/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-ireland/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-poland-english/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-poland-polish/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-turkey/
https://gpcardio.org/en/2019-11-04_epccs-and-primary-cv-care-in-ukraine/
https://gpcardio.org/en/2019-11-05_ticagrelor-alone-versus-dual-antiplatelet-therapy-from-1-month-after-drug-eluting-coronary-stenting/
https://gpcardio.org/en/2019-11-07_five-year-outcomes-after-pci-or-cabg-for-left-main-coronary-disease/
https://gpcardio.org/en/2019-11-12_effect-of-bempedoic-acid-vs-placebo-added-to-maximally-tolerated-statins-on-low-density-lipoprotein-cholesterol-in-patients-at-high-risk-for-cardiovas/
https://gpcardio.org/en/2019-11-12_heart-failure-and-comorbidities-kidney-disease-and-cancer/
https://gpcardio.org/en/2019-11-16_comprehensive-comparative-effectiveness-and-safety-of-first-line-antihypertensive-drug-classes/
https://gpcardio.org/en/2019-11-19_effect-of-empagliflozin-on-left-ventricular-mass-in-patients-with-type-2-diabetes-mellitus-and-coronary-artery-disease/
https://gpcardio.org/en/2019-11-21_dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2019-11-21_ticagrelor-with-or-without-aspirin-in-high-risk-patients-after-pci/
https://gpcardio.org/en/2019-12-26_efficacy-and-safety-of-low-dose-colchicine-after-myocardial-infarction/
https://gpcardio.org/en/2020-01-02_a-comparison-of-two-ldl-cholesterol-targets-after-ischemic-stroke/
https://gpcardio.org/en/2020-01-02_alcohol-abstinence-in-drinkers-with-atrial-fibrillation/
https://gpcardio.org/en/2020-01-09_a-controlled-trial-of-rivaroxaban-after-transcatheter-aortic-valve-replacement/
https://gpcardio.org/en/2020-01-14_effects-of-dapagliflozin-on-symptoms-function-and-quality-of-life-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2020-01-14_efficacy-and-safety-of-dapagliflozin-in-heart-failure-with-reduced-ejection-fraction-according-to-age/
https://gpcardio.org/en/2020-01-16_lipoprotein-a-reduction-in-persons-with-cardiovascular-disease/
https://gpcardio.org/en/2020-01-18_percutaneous-coronary-angioplasty-versus-coronary-artery-bypass-grafting-in-the-treatment-of-unprotected-left-main-stenosis/
https://gpcardio.org/en/2020-01-21_effect-of-renal-denervation-and-catheter-ablation-vs-catheter-ablation-alone-on-atrial-fibrillation-recurrence-among-patients-with-paroxysmal-atrial-f/
https://gpcardio.org/en/2020-02-20_a-community-based-intervention-for-managing-hypertension-in-rural-south-asia/
https://gpcardio.org/en/2020-04-09_initial-invasive-or-conservative-strategy-for-stable-coronary-disease/
https://gpcardio.org/en/2020-04-14_effect-of-dapagliflozin-on-worsening-heart-failure-and-cardiovascular-death-in-patients-with-heart-failure-with-and-without-diabetes/
https://gpcardio.org/en/2020-04-16_inclisiran-for-the-treatment-of-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-04-16_two-phase-3-trials-of-inclisiran-in-patients-with-elevated-ldl-cholesterol/
https://gpcardio.org/en/2020-04-23_management-of-coronary-disease-in-patients-with-advanced-kidney-disease/
https://gpcardio.org/en/2020-04-25_clopidogrel-versus-ticagrelor-or-prasugrel-in-patients-aged-70-years-or-older-with-non-st-elevation-acute-coronary-syndrome-popular-age/
https://gpcardio.org/en/2020-05-01_optimal-antithrombotic-regimens-for-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2020-05-02_efficacy-of-catheter-based-renal-denervation-in-the-absence-of-antihypertensive-medications-spyral-htn-off-med-pivotal/
https://gpcardio.org/en/2020-05-05_ten-year-outcomes-after-drug-eluting-stents-versus-coronary-artery-bypass-grafting-for-left-main-coronary-disease/
https://gpcardio.org/en/2020-05-09_monotherapy-with-a-p2y12-inhibitor-or-aspirin-for-secondary-prevention-in-patients-with-established-atherosclerosis/
https://gpcardio.org/en/2020-05-12_clinical-management-of-stable-coronary-artery-disease-in-patients-with-type-2-diabetes-mellitus/
https://gpcardio.org/en/2020-05-14_vericiguat-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2020-05-19_association-of-blood-pressure-lowering-with-incident-dementia-or-cognitive-impairment/
https://gpcardio.org/en/2020-05-26_effect-of-antihypertensive-medication-reduction-vs-usual-care-on-short-term-blood-pressure-control-in-patients-with-hypertension-aged-80-years-and-old/
https://gpcardio.org/en/2020-05-26_worldwide-prevalence-of-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-06-16_effect-of-ticagrelor-monotherapy-vs-ticagrelor-with-aspirin-on-major-bleeding-and-cardiovascular-events-in-patients-with-acute-coronary-syndrome/
https://gpcardio.org/en/2020-07-07_systemic-amyloidosis-recognition-prognosis-and-therapy/
https://gpcardio.org/en/2020-07-11_estimating-lifetime-benefits-of-comprehensive-disease-modifying-pharmacological-therapies-in-patients-with-heart-failure-with-reduced-ejection-fractio/
https://gpcardio.org/en/2020-07-14_association-of-radial-artery-graft-vs-saphenous-vein-graft-with-long-term-cardiovascular-outcomes-among-patients-undergoing-coronary-artery-bypass-gra/
https://gpcardio.org/en/2020-07-14_comparative-efficacy-and-safety-of-oral-p2y12-inhibitors-in-acute-coronary-syndrome/
https://gpcardio.org/en/2020-08-01_complete-vs-culprit-lesion-only-revascularization-for-st-segment-elevation-myocardial-infarction/
https://gpcardio.org/en/2020-08-04_2020-acc-expert-consensus-decision-pathway-on-management-of-bleeding-in-patients-on-oral-anticoagulants/
https://gpcardio.org/en/2020-08-07_integrated-management-of-atrial-fibrillation-in-primary-care/
https://gpcardio.org/en/2020-08-11_the-safety-and-efficacy-of-aspirin-discontinuation-on-a-background-of-a-p2y12-inhibitor-in-patients-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2020-08-20_evinacumab-for-homozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-08-25_effect-of-genotype-guided-oral-p2y12-inhibitor-selection-vs-conventional-clopidogrel-therapy-on-ischemic-outcomes-after-percutaneous-coronary-interven/
https://gpcardio.org/en/2020-09-01_2020-expert-consensus-decision-pathway-on-novel-therapies-for-cardiovascular-risk-reduction-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2020-09-07_mortality-after-drug-eluting-stents-vs-coronary-artery-bypass-grafting-for-left-main-coronary-artery-disease/
https://gpcardio.org/en/2020-09-14_effects-of-glucagon-like-peptide-1-receptor-agonists-on-major-cardiovascular-events-in-patients-with-type-2-diabetes-mellitus-with-or-without-establis/
https://gpcardio.org/en/2020-09-19_sglt2-inhibitors-in-patients-with-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2020-10-01_early-rhythm-control-therapy-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2020-10-01_evolocumab-in-pediatric-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2020-10-01_natural-history-of-asymptomatic-severe-aortic-stenosis-and-the-association-of-early-intervention-with-outcomes/
https://gpcardio.org/en/2020-10-08_cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/
https://gpcardio.org/en/2020-10-08_cardiovascular-outcomes-with-ertugliflozin-in-type-2-diabetes/
https://gpcardio.org/en/2020-10-08_dapagliflozin-in-patients-with-chronic-kidney-disease/
https://gpcardio.org/en/2020-10-10_prasugrel-based-de-escalation-of-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-in-patients-with-acute-coronary-syndrome-host-redu/
https://gpcardio.org/en/2020-10-13_dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-and-drug-eluting-stents/
https://gpcardio.org/en/2020-10-29_low-dose-edoxaban-in-very-elderly-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2020-10-31_redevelopment-and-validation-of-the-syntax-score-ii-to-individualise-decision-making-between-percutaneous-and-surgical-revascularisation-in-patients-w/
https://gpcardio.org/en/2020-11-07_complete-revascularization-reduces-cardiovascular-death-in-patients-with-st-segment-elevation-myocardial-infarction-and-multivessel-disease/
https://gpcardio.org/en/2020-11-10_screening-for-high-blood-pressure-in-children-and-adolescents/
https://gpcardio.org/en/2020-11-17_colchicine-in-patients-with-acute-coronary-syndrome/
https://gpcardio.org/en/2020-11-21_efficacy-and-safety-of-lowering-ldl-cholesterol-in-older-patients/
https://gpcardio.org/en/2020-11-21_lipoprotein-a-lowering-by-alirocumab-reduces-the-total-burden-of-cardiovascular-events-independent-of-low-density-lipoprotein-cholesterol-lowering/
https://gpcardio.org/en/2020-11-26_n-of-1-trial-of-a-statin-placebo-or-no-treatment-to-assess-side-effects/
https://gpcardio.org/en/2020-11-26_rivaroxaban-in-patients-with-atrial-fibrillation-and-a-bioprosthetic-mitral-valve/
https://gpcardio.org/en/2020-12-08_effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse-cardiovascular-events-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2020-12-10_evinacumab-in-patients-with-refractory-hypercholesterolemia/
https://gpcardio.org/en/2020-12-12_ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/
https://gpcardio.org/en/2020-12-22_effect-of-digoxin-vs-bisoprolol-for-heart-rate-control-in-atrial-fibrillation-on-patient-reported-quality-of-life/
https://gpcardio.org/en/2021-01-14_cardiac-myosin-activation-with-omecamtiv-mecarbil-in-systolic-heart-failure/
https://gpcardio.org/en/2021-01-14_sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2021-01-14_sotagliflozin-in-patients-with-diabetes-and-recent-worsening-heart-failure/
https://gpcardio.org/en/2021-01-21_polypill-with-or-without-aspirin-in-persons-without-cardiovascular-disease/
https://gpcardio.org/en/2021-01-21_short-dual-antiplatelet-therapy-followed-by-p2y12-inhibitor-monotherapy-vs-prolonged-dual-antiplatelet-therapy-after-percutaneous-coronary-interventio/
https://gpcardio.org/en/2021-01-26_randomized-trial-of-empagliflozin-in-nondiabetic-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2021-01-28_cryoablation-or-drug-therapy-for-initial-treatment-of-atrial-fibrillation/
https://gpcardio.org/en/2021-01-28_cryoballoon-ablation-as-initial-therapy-for-atrial-fibrillation/
https://gpcardio.org/en/2021-01-28_inhaled-treprostinil-in-pulmonary-hypertension-due-to-interstitial-lung-disease/
https://gpcardio.org/en/2021-02-01_association-of-sglt2-inhibitors-with-cardiovascular-and-kidney-outcomes-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2021-02-09_2020-acc-expert-consensus-decision-pathway-for-anticoagulant-and-antiplatelet-therapy-in-patients-with-atrial-fibrillation-or-venous-thromboembolism-u/
https://gpcardio.org/en/2021-02-09_effect-of-high-intensity-interval-training-moderate-continuous-training-or-guideline-based-physical-activity-advice-on-peak-oxygen-consumption-in-pati/
https://gpcardio.org/en/2021-02-09_finerenone-and-cardiovascular-outcomes-in-patients-with-chronic-kidney-disease-and-type-2-diabetes/
https://gpcardio.org/en/2021-02-16_2021-update-to-the-2017-acc-expert-consensus-decision-pathway-for-optimization-of-heart-failure-treatment/
https://gpcardio.org/en/2021-03-02_3-year-outcomes-of-transcatheter-mitral-valve-repair-in-patients-with-heart-failure/
https://gpcardio.org/en/2021-03-16_effect-of-marine-omega-3-fatty-acid-and-vitamin-d-supplementation-on-incident-atrial-fibrillation/
https://gpcardio.org/en/2021-03-31_effects-of-dapagliflozin-on-mortality-in-patients-with-chronic-kidney-disease/
https://gpcardio.org/en/2021-04-07_2020-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-presenting-without-persistent-st-segment-elevation/
https://gpcardio.org/en/2021-04-17_guided-versus-standard-antiplatelet-therapy-in-patients-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2021-05-01_pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of-cardiovascular-disease-across-different-levels-of-blood-pressure/
https://gpcardio.org/en/2021-05-05_do-β-blockers-cause-depression/
https://gpcardio.org/en/2021-05-20_final-report-of-a-trial-of-intensive-versus-standard-blood-pressure-control/
https://gpcardio.org/en/2021-05-27_comparative-effectiveness-of-aspirin-dosing-in-cardiovascular-disease/
https://gpcardio.org/en/2021-06-01_assessment-of-catheter-ablation-or-antiarrhythmic-drugs-for-first-line-therapy-of-atrial-fibrillation/
https://gpcardio.org/en/2021-06-03_left-atrial-appendage-occlusion-during-cardiac-surgery-to-prevent-stroke/
https://gpcardio.org/en/2021-06-26_aspirin-versus-clopidogrel-for-chronic-maintenance-monotherapy-after-percutaneous-coronary-intervention-host-exam/
https://gpcardio.org/en/2021-06-26_ultrasound-renal-denervation-for-hypertension-resistant-to-a-triple-medication-pill-radiance-htn-trio/
https://gpcardio.org/en/2021-07-10_efficacy-and-safety-of-a-novel-dual-gip-and-glp-1-receptor-agonist-tirzepatide-in-patients-with-type-2-diabetes-surpass-1/
https://gpcardio.org/en/2021-07-15_physical-rehabilitation-for-older-patients-hospitalized-for-heart-failure/
https://gpcardio.org/en/2021-07-21_efficacy-and-safety-of-low-dose-colchicine-in-patients-with-coronary-disease/
https://gpcardio.org/en/2021-07-22_multivessel-pci-guided-by-ffr-or-angiography-for-myocardial-infarction/
https://gpcardio.org/en/2021-08-05_milrinone-as-compared-with-dobutamine-in-the-treatment-of-cardiogenic-shock/
https://gpcardio.org/en/2021-08-14_once-weekly-tirzepatide-versus-once-daily-insulin-degludec-as-add-on-to-metformin-with-or-without-sglt2-inhibitors-in-patients-with-type-2-diabetes-su/
https://gpcardio.org/en/2021-08-17_lowering-cholesterol-blood-pressure-or-both-to-prevent-cardiovascular-events/
https://gpcardio.org/en/2021-08-31_2021-acc-expert-consensus-decision-pathway-on-the-management-of-ascvd-risk-reduction-in-patients-with-persistent-hypertriglyceridemia/
https://gpcardio.org/en/2021-09-02_cardiovascular-and-renal-outcomes-with-efpeglenatide-in-type-2-diabetes/
https://gpcardio.org/en/2021-09-11_haemodynamic-guided-management-of-heart-failure-guide-hf/
https://gpcardio.org/en/2021-09-16_effect-of-salt-substitution-on-cardiovascular-events-and-death/
https://gpcardio.org/en/2021-09-18_initial-treatment-with-a-single-pill-containing-quadruple-combination-of-quarter-doses-of-blood-pressure-medicines-versus-standard-dose-monotherapy-in/
https://gpcardio.org/en/2021-09-30_trial-of-intensive-blood-pressure-control-in-older-patients-with-hypertension/
https://gpcardio.org/en/2021-10-09_unguided-de-escalation-from-ticagrelor-to-clopidogrel-in-stabilised-patients-with-acute-myocardial-infarction-undergoing-percutaneous-coronary-interve/
https://gpcardio.org/en/2021-10-14_empagliflozin-and-major-renal-outcomes-in-heart-failure/
https://gpcardio.org/en/2021-10-14_empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/
https://gpcardio.org/en/2021-10-19_effect-of-empagliflozin-on-worsening-heart-failure-events-in-patients-with-heart-failure-and-preserved-ejection-fraction/
https://gpcardio.org/en/2021-10-23_clinical-outcomes-in-systematic-screening-for-atrial-fibrillation-strokestop/
https://gpcardio.org/en/2021-10-28_dual-antiplatelet-therapy-after-pci-in-patients-at-high-bleeding-risk/
https://gpcardio.org/en/2021-11-02_influenza-vaccination-after-myocardial-infarction/
https://gpcardio.org/en/2021-11-11_angiotensin-receptor-neprilysin-inhibition-in-acute-myocardial-infarction/
https://gpcardio.org/en/2021-11-13_blood-pressure-lowering-and-risk-of-new-onset-type-2-diabetes/
https://gpcardio.org/en/2021-11-13_tirzepatide-versus-insulin-glargine-in-type-2-diabetes-and-increased-cardiovascular-risk-surpass-4/
https://gpcardio.org/en/2021-12-02_edoxaban-versus-vitamin-k-antagonist-for-atrial-fibrillation-after-tavr/
https://gpcardio.org/en/2021-12-04_posterior-left-pericardiotomy-for-the-prevention-of-atrial-fibrillation-after-cardiac-surgery/
https://gpcardio.org/en/2021-12-07_av-junction-ablation-and-cardiac-resynchronization-for-patients-with-permanent-atrial-fibrillation-and-narrow-qrs/
https://gpcardio.org/en/2021-12-09_cardiovascular-events-with-finerenone-in-kidney-disease-and-type-2-diabetes/
https://gpcardio.org/en/2021-12-11_angiographic-quantitative-flow-ratio-guided-coronary-intervention-favor-iii-china/
https://gpcardio.org/en/2021-12-18_percutaneous-coronary-intervention-with-drug-eluting-stents-versus-coronary-artery-bypass-grafting-in-left-main-coronary-artery-disease/
https://gpcardio.org/en/2021-12-21_effect-of-long-term-marine-3-fatty-acids-supplementation-on-the-risk-of-atrial-fibrillation-in-randomized-controlled-trials-of-cardiovascular-outcomes/
https://gpcardio.org/en/2021-12-30_angiography-after-out-of-hospital-cardiac-arrest-without-st-segment-elevation/
https://gpcardio.org/en/2021-12-30_chlorthalidone-for-hypertension-in-advanced-chronic-kidney-disease/
https://gpcardio.org/en/2022-01-13_fractional-flow-reserve-guided-pci-as-compared-with-coronary-bypass-surgery/
https://gpcardio.org/en/2022-01-18_2021-acc-aha-scai-guideline-for-coronary-artery-revascularization/
https://gpcardio.org/en/2022-01-25_direct-oral-anticoagulants-versus-warfarin-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2022-01-25_screening-for-atrial-fibrillation/
https://gpcardio.org/en/2022-02-08_finerenone-reduces-risk-of-incident-heart-failure-in-patients-with-chronic-kidney-disease-and-type-2-diabetes/
https://gpcardio.org/en/2022-02-10_cardiovascular-and-kidney-outcomes-with-finerenone-in-patients-with-type-2-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2022-03-07_comparative-effects-of-guided-vs-potent-p2y12-inhibitor-therapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2022-03-21_systematic-early-rhythm-control-strategy-for-atrial-fibrillation-in-patients-with-or-without-symptoms/
https://gpcardio.org/en/2022-04-09_reduction-of-dietary-sodium-to-less-than-100-mmol-in-heart-failure-sodium-hf/
https://gpcardio.org/en/2022-04-09_safety-of-the-oral-factor-xia-inhibitor-asundexian-compared-with-apixaban-in-patients-with-atrial-fibrillation-pacific-af/
https://gpcardio.org/en/2022-04-26_aspirin-use-to-prevent-cardiovascular-disease/
https://gpcardio.org/en/2022-05-03_2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/
https://gpcardio.org/en/2022-05-03_2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/
https://gpcardio.org/en/2022-05-03_2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/
https://gpcardio.org/en/2022-05-10_effect-of-alirocumab-added-to-high-intensity-statin-therapy-on-coronary-atherosclerosis-in-patients-with-acute-myocardial-infarction/
https://gpcardio.org/en/2022-05-12_treatment-for-mild-chronic-hypertension-during-pregnancy/
https://gpcardio.org/en/2022-05-21_bariatric-surgery-and-cardiovascular-disease/
https://gpcardio.org/en/2022-05-31_effects-of-long-term-metformin-and-lifestyle-interventions-on-cardiovascular-events-in-the-diabetes-prevention-program-and-its-outcome-study/
https://gpcardio.org/en/2022-06-02_need-to-restart-and-catch-up-in-cvd-prevention-in-time-of-covid-19/
https://gpcardio.org/en/2022-06-07_randomized-ablation-based-rhythm-control-versus-rate-control-trial-in-patients-with-heart-failure-and-atrial-fibrillation/
https://gpcardio.org/en/2022-06-21_does-timing-of-ventricular-tachycardia-ablation-affect-prognosis-in-patients-with-an-implantable-cardioverter-defibrillator-results-from-the-multicent/
https://gpcardio.org/en/2022-06-21_effect-of-mri-guided-fibrosis-ablation-vs-conventional-catheter-ablation-on-atrial-arrhythmia-recurrence-in-patients-with-persistent-atrial-fibrillati/
https://gpcardio.org/en/2022-07-19_effect-of-omecamtiv-mecarbil-on-exercise-capacity-in-chronic-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2022-07-26_behavioral-counseling-interventions-to-promote-a-healthy-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-without-cardiovasc/
https://gpcardio.org/en/2022-07-26_effects-of-early-empagliflozin-initiation-on-diuresis-and-kidney-function-in-patients-with-acute-decompensated-heart-failure-empag-hf/
https://gpcardio.org/en/2022-07-26_effects-of-empagliflozin-on-symptoms-physical-limitations-and-quality-of-life-in-patients-hospitalized-for-acute-heart-failure/
https://gpcardio.org/en/2022-07-30_long-term-efficacy-and-safety-of-moderate-intensity-statin-with-ezetimibe-combination-therapy-versus-high-intensity-statin-monotherapy-in-patients-wit/
https://gpcardio.org/en/2022-08-09_initial-decline-dip-in-estimated-glomerular-filtration-rate-after-initiation-of-dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-frac/
https://gpcardio.org/en/2022-08-23_statin-use-for-the-primary-prevention-of-cardiovascular-disease-in-adults/
https://gpcardio.org/en/2022-08-23_statin-use-for-the-primary-prevention-of-cardiovascular-disease-in-adults/
https://gpcardio.org/en/2022-08-30_empagliflozin-for-heart-failure-with-preserved-left-ventricular-ejection-fraction-with-and-without-diabetes/
https://gpcardio.org/en/2022-09-01_fractional-flow-reserve-or-intravascular-ultrasonography-to-guide-pci/
https://gpcardio.org/en/2022-09-03_sglt-2-inhibitors-in-patients-with-heart-failure/
https://gpcardio.org/en/2022-09-07_prevalence-of-statin-intolerance/
https://gpcardio.org/en/2022-09-08_routine-functional-testing-or-standard-care-in-high-risk-patients-after-pci/
https://gpcardio.org/en/2022-09-10_effect-of-statin-therapy-on-muscle-symptoms/
https://gpcardio.org/en/2022-09-13_early-rhythm-control-in-patients-with-atrial-fibrillation-and-high-comorbidity-burden/
https://gpcardio.org/en/2022-09-15_polypill-strategy-in-secondary-cardiovascular-prevention/
https://gpcardio.org/en/2022-09-15_rivaroxaban-in-rheumatic-heart-disease-associated-atrial-fibrillation/
https://gpcardio.org/en/2022-09-20_harmonization-of-the-american-college-of-cardiology-american-heart-association-and-european-society-of-cardiology-european-society-of-hypertension-blo/
https://gpcardio.org/en/2022-09-22_dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2022-09-22_glycemia-reduction-in-type-2-diabetes-microvascular-and-cardiovascular-outcomes/
https://gpcardio.org/en/2022-09-26_effects-of-salt-substitutes-on-clinical-outcomes/
https://gpcardio.org/en/2022-09-27_five-year-outcomes-in-patients-with-fully-magnetically-levitated-vs-axial-flow-left-ventricular-assist-devices-in-the-momentum-3-randomized-trial/
https://gpcardio.org/en/2022-09-27_randomized-trial-of-left-bundle-branch-vs-biventricular-pacing-for-cardiac-resynchronization-therapy/
https://gpcardio.org/en/2022-09-29_acetazolamide-in-acute-decompensated-heart-failure-with-volume-overload/
https://gpcardio.org/en/2022-10-04_2022-acc-expert-consensus-decision-pathway-on-the-role-of-nonstatin-therapies-for-ldl-cholesterol-lowering-in-the-management-of-atherosclerotic-cardio/
https://gpcardio.org/en/2022-10-04_dapagliflozin-in-patients-recently-hospitalized-with-heart-failure-and-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2022-10-04_early-versus-delayed-non-vitamin-k-antagonist-oral-anticoagulant-therapy-after-acute-ischemic-stroke-in-atrial-fibrillation-timing/
https://gpcardio.org/en/2022-10-08_allopurinol-versus-usual-care-in-uk-patients-with-ischaemic-heart-disease-all-heart/
https://gpcardio.org/en/2022-10-13_percutaneous-revascularization-for-ischemic-left-ventricular-dysfunction/
https://gpcardio.org/en/2022-10-18_efficacy-and-safety-of-dapagliflozin-according-to-frailty-in-patients-with-heart-failure/
https://gpcardio.org/en/2022-10-20_blood-pressure-targets-in-comatose-survivors-of-cardiac-arrest/
https://gpcardio.org/en/2022-10-22_cardiovascular-outcomes-in-adults-with-hypertension-with-evening-versus-morning-dosing-of-usual-antihypertensives-in-the-uk-time-study/
https://gpcardio.org/en/2022-11-01_empagliflozin-in-acute-myocardial-infarction/
https://gpcardio.org/en/2022-11-01_patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2022-11-05_intensive-blood-pressure-control-after-endovascular-thrombectomy-for-acute-ischaemic-stroke-enchanted2-mt/
https://gpcardio.org/en/2022-11-15_hospitalizations-and-mortality-in-patients-with-secondary-mitral-regurgitation-and-heart-failure/
https://gpcardio.org/en/2022-11-17_small-interfering-rna-to-reduce-lipoprotein-a-in-cardiovascular-disease/
https://gpcardio.org/en/2022-11-19_impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors-on-kidney-outcomes/
https://gpcardio.org/en/2022-11-22_everolimus-eluting-stents-or-bypass-surgery-for-multivessel-coronary-artery-disease/
https://gpcardio.org/en/2022-11-24_triglyceride-lowering-with-pemafibrate-to-reduce-cardiovascular-risk/
https://gpcardio.org/en/2022-11-26_ly3437943-a-novel-triple-gip-glp-1-and-glucagon-receptor-agonist-in-people-with-type-2-diabetes/
https://gpcardio.org/en/2022-12-03_dual-endothelin-antagonist-aprocitentan-for-resistant-hypertension-precision/
https://gpcardio.org/en/2022-12-03_safety-tolerability-and-efficacy-of-up-titration-of-guideline-directed-medical-therapies-for-acute-heart-failure-strong-hf/
https://gpcardio.org/en/2022-12-06_apixaban-for-patients-with-atrial-fibrillation-on-hemodialysis/
https://gpcardio.org/en/2022-12-17_intravenous-ferric-derisomaltose-in-patients-with-heart-failure-and-iron-deficiency-in-the-uk-ironman/
https://gpcardio.org/en/2022-12-21_blood-pressure-lowering-and-prevention-of-dementia/
https://gpcardio.org/en/2022-12-29_chlorthalidone-vs-hydrochlorothiazide-for-hypertension-cardiovascular-events/
https://gpcardio.org/en/2023-01-01_impact-of-empagliflozin-on-decongestion-in-acute-heart-failure/
https://gpcardio.org/en/2023-01-03_comparative-effects-of-low-dose-rosuvastatin-placebo-and-dietary-supplements-on-lipids-and-inflammatory-biomarkers/
https://gpcardio.org/en/2023-01-03_phase-2-study-of-aficamten-in-patients-with-obstructive-hypertrophic-cardiomyopathy/
https://gpcardio.org/en/2023-01-03_survival-after-invasive-or-conservative-management-of-stable-coronary-disease/
https://gpcardio.org/en/2023-01-10_aspirin-versus-clopidogrel-for-long-term-maintenance-monotherapy-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2023-01-10_effect-of-catheter-ablation-using-pulmonary-vein-isolation-with-vs-without-posterior-left-atrial-wall-isolation-on-atrial-arrhythmia-recurrence-in-pat/
https://gpcardio.org/en/2023-01-10_prospective-association-of-daily-steps-with-cardiovascular-disease/
https://gpcardio.org/en/2023-01-12_empagliflozin-in-patients-with-chronic-kidney-disease/
https://gpcardio.org/en/2023-01-12_progression-of-atrial-fibrillation-after-cryoablation-or-drug-therapy/
https://gpcardio.org/en/2023-01-14_cost-effectiveness-of-population-screening-for-atrial-fibrillation/
https://gpcardio.org/en/2023-01-17_effect-of-torsemide-vs-furosemide-after-discharge-on-all-cause-mortality-in-patients-hospitalized-with-heart-failure/
https://gpcardio.org/en/2023-02-01_combining-loop-with-thiazide-diuretics-for-decompensated-heart-failure/
https://gpcardio.org/en/2023-02-02_phase-2-trial-of-baxdrostat-for-treatment-resistant-hypertension/
https://gpcardio.org/en/2023-02-07_extracorporeal-membrane-oxygenation-in-the-therapy-of-cardiogenic-shock/
https://gpcardio.org/en/2023-02-16_catheter-ablation-improves-cardiovascular-outcomes-in-patients-with-atrial-fibrillation-and-heart-failure/
https://gpcardio.org/en/2023-02-28_endovascular-ultrasound-renal-denervation-to-treat-hypertension/
https://gpcardio.org/en/2023-02-28_incidental-coronary-artery-calcium/
https://gpcardio.org/en/2023-03-18_effectiveness-of-a-non-physician-community-health-care-provider-led-intensive-blood-pressure-intervention-versus-usual-care-on-cardiovascular-disease-/
https://gpcardio.org/en/2023-04-04_treat-to-target-or-high-intensity-statin-in-patients-with-coronary-artery-disease/
https://gpcardio.org/en/2023-04-08_immediate-versus-staged-complete-revascularisation-in-patients-presenting-with-acute-coronary-syndrome-and-multivessel-coronary-disease-biovasc/
https://gpcardio.org/en/2023-04-11_heterogeneity-in-blood-pressure-response-to-4-antihypertensive-drugs/
https://gpcardio.org/en/2023-04-13_bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/
https://gpcardio.org/en/2023-04-15_inflammation-and-cholesterol-as-predictors-of-cardiovascular-events-among-patients-receiving-statin-therapy/
https://gpcardio.org/en/2023-04-17_dual-antiplatelet-therapy-de-escalation-in-acute-coronary-syndrome/
https://gpcardio.org/en/2023-04-18_association-between-achieved-low-density-lipoprotein-cholesterol-levels-and-long-term-cardiovascular-and-safety-outcomes/
https://gpcardio.org/en/2023-04-20_phase-3-trial-of-sotatercept-for-treatment-of-pulmonary-arterial-hypertension/
https://gpcardio.org/en/2023-04-25_phase-2b-randomized-trial-of-the-oral-pcsk9-inhibitor-mk-0616/
https://gpcardio.org/en/2023-05-04_intravascular-imaging-guided-or-angiography-guided-complex-pci/
https://gpcardio.org/en/2023-05-09_2023-acc-expert-consensus-decision-pathway-on-management-of-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2023-05-18_transcatheter-repair-for-patients-with-tricuspid-regurgitation/
https://gpcardio.org/en/2023-05-27_a-vein-bypass-first-versus-a-best-endovascular-treatment-first-revascularisation-strategy-for-patients-with-chronic-limb-threatening-ischaemia-who-req/
https://gpcardio.org/en/2023-06-01_efficacy-and-safety-of-low-dose-triple-and-quadruple-combination-pills-vs-monotherapy-usual-care-or-placebo-for-the-initial-management-of-hypertension/
https://gpcardio.org/en/2023-06-01_five-year-follow-up-after-transcatheter-repair-of-secondary-mitral-regurgitation/
https://gpcardio.org/en/2023-06-06_direct-oral-anticoagulants-versus-warfarin-across-the-spectrum-of-kidney-function/
https://gpcardio.org/en/2023-06-06_uptitrating-treatment-after-heart-failure-hospitalization-across-the-spectrum-of-left-ventricular-ejection-fraction/
https://gpcardio.org/en/2023-06-08_treatment-of-gestational-diabetes-mellitus-diagnosed-early-in-pregnancy/
https://gpcardio.org/en/2023-06-24_remote-haemodynamic-monitoring-of-pulmonary-artery-pressures-in-patients-with-chronic-heart-failure-monitor-hf/
https://gpcardio.org/en/2023-06-27_effect-of-sglt2-inhibitors-on-cardiovascular-outcomes-across-various-patient-populations/
https://gpcardio.org/en/2023-06-29_early-versus-later-anticoagulation-for-stroke-with-atrial-fibrillation/
https://gpcardio.org/en/2023-07-01_the-third-intensive-care-bundle-with-blood-pressure-reduction-in-acute-cerebral-haemorrhage-trial-interact3/
https://gpcardio.org/en/2023-07-11_p2y12-inhibitor-or-aspirin-monotherapy-for-secondary-prevention-of-coronary-events/
https://gpcardio.org/en/2023-07-13_cardiovascular-safety-of-testosterone-replacement-therapy/
https://gpcardio.org/en/2023-07-20_phase-1-trial-of-antibody-ni006-for-depletion-of-cardiac-transthyretin-amyloid/
https://gpcardio.org/en/2023-07-20_zilebesiran-an-rna-interference-therapeutic-agent-for-hypertension/
https://gpcardio.org/en/2023-08-08_atorvastatin-for-anthracycline-associated-cardiac-dysfunction/
https://gpcardio.org/en/2023-08-08_glp-1-receptor-agonist-therapy-with-and-without-sglt2-inhibitors-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2023-08-12_retatrutide-a-gip-glp-1-and-glucagon-receptor-agonist-for-people-with-type-2-diabetes/
https://gpcardio.org/en/2023-08-14_sacubitril-valsartan-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2023-08-24_fixed-dose-combination-therapies-in-primary-cardiovascular-disease-prevention-in-different-groups/
https://gpcardio.org/en/2023-08-24_pitavastatin-to-prevent-cardiovascular-disease-in-hiv-infection/
https://gpcardio.org/en/2023-09-07_complete-or-culprit-only-pci-in-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2023-09-07_daily-oral-glp-1-receptor-agonist-orforglipron-for-adults-with-obesity/
https://gpcardio.org/en/2023-09-14_ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2023-09-19_fractional-flow-reserve-guided-pci-or-coronary-bypass-surgery-for-3-vessel-coronary-artery-disease/
https://gpcardio.org/en/2023-09-21_semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and-obesity/
https://gpcardio.org/en/2023-09-28_anticoagulation-with-edoxaban-in-patients-with-atrial-high-rate-episodes/
https://gpcardio.org/en/2023-10-01_efficacy-of-pulmonary-artery-pressure-monitoring-in-patients-with-chronic-heart-failure/
https://gpcardio.org/en/2023-10-01_mineralocorticoid-receptor-antagonists-with-sodium-glucose-co-transporter-2-inhibitors-in-heart-failure/
https://gpcardio.org/en/2023-10-03_estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/
https://gpcardio.org/en/2023-10-05_extracorporeal-life-support-in-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2023-10-05_global-effect-of-modifiable-risk-factors-on-cardiovascular-disease-and-mortality/
https://gpcardio.org/en/2023-10-12_catheter-ablation-in-end-stage-heart-failure-with-atrial-fibrillation/
https://gpcardio.org/en/2023-10-12_timing-of-complete-revascularization-with-multivessel-pci-for-myocardial-infarction/
https://gpcardio.org/en/2023-10-14_venoarterial-extracorporeal-membrane-oxygenation-in-patients-with-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2023-10-17_optical-coherence-tomography-guided-or-intravascular-ultrasound-guided-percutaneous-coronary-intervention/
https://gpcardio.org/en/2023-10-17_orthostatic-hypotension-hypertension-treatment-and-cardiovascular-disease/
https://gpcardio.org/en/2023-10-19_oct-or-angiography-guidance-for-pci-in-complex-bifurcation-lesions/
https://gpcardio.org/en/2023-10-19_optical-coherence-tomography-guided-versus-angiography-guided-pci/
https://gpcardio.org/en/2023-10-24_traditional-chinese-medicine-compound-tongxinluo-and-clinical-outcomes-of-patients-with-acute-myocardial-infarction/
https://gpcardio.org/en/2023-11-02_pulsed-field-or-conventional-thermal-ablation-for-paroxysmal-atrial-fibrillation/
https://gpcardio.org/en/2023-11-23_transcatheter-aortic-valve-replacement-in-low-risk-patients-at-five-years/
https://gpcardio.org/en/2023-11-25_zibotentan-in-combination-with-dapagliflozin-compared-with-dapagliflozin-in-patients-with-chronic-kidney-disease-zenith-ckd/
https://gpcardio.org/en/2023-12-14_semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/
https://gpcardio.org/en/2023-12-21_a-placebo-controlled-trial-of-percutaneous-coronary-intervention-for-stable-angina/
https://gpcardio.org/en/2023-12-21_efficacy-of-ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2023-12-28_restrictive-or-liberal-transfusion-strategy-in-myocardial-infarction-and-anemia/
https://gpcardio.org/en/2024-01-02_2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial-fibrillation/
https://gpcardio.org/en/2024-01-02_2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial-fibrillation/
https://gpcardio.org/en/2024-01-11_apixaban-for-stroke-prevention-in-subclinical-atrial-fibrillation/
https://gpcardio.org/en/2024-01-18_long-term-outcomes-of-resynchronization-defibrillation-for-heart-failure/
https://gpcardio.org/en/2024-02-13_implantable-hemodynamic-monitors-improve-survival-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2024-02-20_an-aspirin-free-versus-dual-antiplatelet-strategy-for-coronary-stenting/
https://gpcardio.org/en/2024-02-20_safety-and-efficacy-of-ticagrelor-monotherapy-in-patients-with-acute-coronary-syndromes-undergoing-percutaneous-coronary-intervention/
https://gpcardio.org/en/2024-02-20_stopping-aspirin-within-1-month-after-stenting-for-ticagrelor-monotherapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2024-03-01_impact-of-bempedoic-acid-on-total-cardiovascular-events/
https://gpcardio.org/en/2024-03-02_intravascular-imaging-guided-coronary-drug-eluting-stent-implantation/
https://gpcardio.org/en/2024-03-18_global-shift-from-underweight-to-obesity-dominance-in-three-decades-across-generations/
https://gpcardio.org/en/2024-03-26_direct-oral-anticoagulants-for-stroke-prevention-in-patients-with-device-detected-atrial-fibrillation/
https://gpcardio.org/en/2024-04-01_transcatheter-or-surgical-aortic-valve-implantation/
https://gpcardio.org/en/2024-04-02_stratify-hf-a-european-collaboration-to-develop-an-ai-based-support-system-for-risk-stratification-and-early-detection-of-heart-failure/
https://gpcardio.org/en/2024-04-07_gamification-and-financial-incentives-to-increase-physical-activity-among-patients-at-elevated-cv-risk/
https://gpcardio.org/en/2024-04-08_enhanced-remote-medication-program-boosts-gdmt-prescriptions-for-high-cv-or-kidney-risk-in-t2d-patients/
https://gpcardio.org/en/2024-04-08_web-app-effective-in-determining-access-to-statins-without-a-prescription/
https://gpcardio.org/en/2024-04-16_2024-acc-expert-consensus-decision-pathway-for-treatment-of-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2024-04-18_beta-blockers-after-myocardial-infarction-and-preserved-ejection-fraction/
https://gpcardio.org/en/2024-04-18_microaxial-flow-pump-or-standard-care-in-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2024-04-18_semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/
https://gpcardio.org/en/2024-04-25_empagliflozin-after-acute-myocardial-infarction/
https://gpcardio.org/en/2024-04-25_ffr-guided-complete-or-culprit-only-pci-in-patients-with-myocardial-infarction/
https://gpcardio.org/en/2024-04-27_semaglutide-versus-placebo-in-people-with-obesity-related-heart-failure-with-preserved-ejection-fraction/
https://gpcardio.org/en/2024-05-01_ticagrelor-or-clopidogrel-monotherapy-vs-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention/
https://gpcardio.org/en/2024-05-02_apolipoprotein-a1-infusions-and-cardiovascular-outcomes-after-acute-myocardial-infarction/
https://gpcardio.org/en/2024-05-04_preventive-percutaneous-coronary-intervention-versus-optimal-medical-therapy-alone-for-the-treatment-of-vulnerable-atherosclerotic-coronary-plaques-pr/
https://gpcardio.org/en/2024-05-04_stratifyhf-providing-support-to-primary-care-in-early-diagnosis-of-heart-failure/
https://gpcardio.org/en/2024-05-06_the-stratifyhf-research-and-innovation-action/
https://gpcardio.org/en/2024-05-11_intravascular-ultrasound-guided-versus-angiography-guided-percutaneous-coronary-intervention-in-acute-coronary-syndromes-ivus-acs/
https://gpcardio.org/en/2024-05-11_ticagrelor-alone-versus-ticagrelor-plus-aspirin-from-month-1-to-month-12-after-percutaneous-coronary-intervention-in-patients-with-acute-coronary-synd/
https://gpcardio.org/en/2024-05-16_andexanet-for-factor-xa-inhibitor-associated-acute-intracerebral-hemorrhage/
https://gpcardio.org/en/2024-05-16_olezarsen-acute-pancreatitis-and-familial-chylomicronemia-syndrome/
https://gpcardio.org/en/2024-05-16_olezarsen-for-hypertriglyceridemia-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2024-05-30_intensive-ambulance-delivered-blood-pressure-reduction-in-hyperacute-stroke/
https://gpcardio.org/en/2024-06-01_pulmonary-arterial-hypertension-treatment/
https://gpcardio.org/en/2024-06-04_enhancing-cvd-risk-assessment-integrating-genetic-risk-for-improved-prediction/
https://gpcardio.org/en/2024-06-04_sodium-glucose-cotransporter-2-inhibitors-and-major-adverse-cardiovascular-outcomes/
https://gpcardio.org/en/2024-06-06_self-expanding-or-balloon-expandable-tavr-in-patients-with-a-small-aortic-annulus/
https://gpcardio.org/en/2024-06-14_invasive-vs-conservative-management-of-older-patients-with-non-st-elevation-acute-coronary-syndrome/
https://gpcardio.org/en/2024-06-25_revisiting-race-and-the-benefit-of-ras-blockade-in-heart-failure/
https://gpcardio.org/en/2024-07-01_plozasiran-aro-apoc3-for-severe-hypertriglyceridemia/
https://gpcardio.org/en/2024-07-11_effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2024-07-13_long-term-colchicine-for-the-prevention-of-vascular-recurrent-events-in-non-cardioembolic-stroke-convince/
https://gpcardio.org/en/2024-07-20_lowering-systolic-blood-pressure-to-less-than-120-mm-hg-versus-less-than-140-mm-hg-in-patients-with-high-cardiovascular-risk-with-and-without-diabetes/
https://gpcardio.org/en/2024-08-24_semaglutide-and-cardiovascular-outcomes-in-patients-with-obesity-and-prevalent-heart-failure/
https://gpcardio.org/en/2024-09-01_ticagrelor-monotherapy-for-acute-coronary-syndrome/
https://gpcardio.org/en/2024-09-04_global-insights-from-the-interaspire-study-mapping-lipoprotein-a-prevalence-in-coronary-heart-disease-across-six-who-regions/
https://gpcardio.org/en/2024-09-07_semaglutide-versus-placebo-in-patients-with-heart-failure-and-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2024-09-12_plozasiran-an-rna-interference-agent-targeting-apoc3-for-mixed-hyperlipidemia/
https://gpcardio.org/en/2024-09-12_zodasiran-an-rnai-therapeutic-targeting-angptl3-for-mixed-hyperlipidemia/
https://gpcardio.org/en/2024-09-14_temporary-mechanical-circulatory-support-in-infarct-related-cardiogenic-shock/
https://gpcardio.org/en/2024-09-21_mineralocorticoid-receptor-antagonists-in-heart-failure/
https://gpcardio.org/en/2024-09-24_2024-acc-expert-consensus-decision-pathway-on-clinical-assessment-management-and-trajectory-of-patients-hospitalized-with-heart-failure-focused-update/
https://gpcardio.org/en/2024-09-29_2024-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-the-european-association-for-cardio-thoracic-surgery-eac/
https://gpcardio.org/en/2024-10-07_2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension/
https://gpcardio.org/en/2024-10-07_semaglutide-and-blood-pressure/
https://gpcardio.org/en/2024-10-10_beta-blocker-interruption-or-continuation-after-myocardial-infarction/
https://gpcardio.org/en/2024-10-22_effects-of-semaglutide-on-heart-failure-outcomes-in-diabetes-and-chronic-kidney-disease-in-the-flow-trial/
https://gpcardio.org/en/2024-10-24_finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2024-10-29_adjudication-of-hospitalizations-and-deaths-in-the-ironman-trial-of-intravenous-iron-for-heart-failure/
https://gpcardio.org/en/2024-11-05_complete-versus-culprit-only-revascularization-in-older-patients-with-st-segment-elevation-myocardial-infarction/
https://gpcardio.org/en/2024-11-07_invasive-treatment-strategy-for-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2024-11-09_quantitative-flow-ratio-versus-fractional-flow-reserve-for-coronary-revascularisation-guidance-favor-iii-europe/
https://gpcardio.org/en/2024-11-14_transcatheter-repair-versus-mitral-valve-surgery-for-secondary-mitral-regurgitation/
https://gpcardio.org/en/2024-11-14_transcatheter-valve-repair-in-heart-failure-with-moderate-to-severe-mitral-regurgitation/
https://gpcardio.org/en/2024-11-19_effect-of-screening-for-undiagnosed-atrial-fibrillation-on-stroke-prevention/
https://gpcardio.org/en/2024-11-26_cardiovascular-kidney-and-safety-outcomes-with-glp-1-receptor-agonists-alone-and-in-combination-with-sglt2-inhibitors-in-type-2-diabetes/
https://gpcardio.org/en/2024-12-12_pci-in-patients-undergoing-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2024-12-14_the-vital-role-of-primary-care-in-advancing-cardiovascular-health/
https://gpcardio.org/en/2025-01-02_asundexian-versus-apixaban-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2025-01-07_efficacy-and-safety-of-finerenone-across-the-ejection-fraction-spectrum-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2025-01-09_plozasiran-for-managing-persistent-chylomicronemia-and-pancreatitis-risk/
https://gpcardio.org/en/2025-01-09_transcatheter-valve-replacement-in-severe-tricuspid-regurgitation/
https://gpcardio.org/en/2025-01-14_transcatheter-edge-to-edge-repair-for-severe-isolated-tricuspid-regurgitation/
https://gpcardio.org/en/2025-01-21_early-intervention-in-patients-with-asymptomatic-severe-aortic-stenosis-and-myocardial-fibrosis/
https://gpcardio.org/en/2025-01-21_oral-muvalaplin-for-lowering-of-lipoprotein-a/
https://gpcardio.org/en/2025-01-23_abelacimab-versus-rivaroxaban-in-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2025-01-25_coronary-ct-angiography-guided-management-of-patients-with-stable-chest-pain/
https://gpcardio.org/en/2025-01-30_continuation-versus-interruption-of-oral-anticoagulation-during-tavi/
https://gpcardio.org/en/2025-01-30_tirzepatide-for-heart-failure-with-preserved-ejection-fraction-and-obesity/
https://gpcardio.org/en/2025-02-13_colchicine-in-acute-myocardial-infarction/
https://gpcardio.org/en/2025-02-13_routine-spironolactone-in-acute-myocardial-infarction/
https://gpcardio.org/en/2025-02-20_catheter-ablation-or-antiarrhythmic-drugs-for-ventricular-tachycardia/
https://gpcardio.org/en/2025-03-11_transcatheter-aortic-valve-replacement-in-patients-with-systolic-heart-failure-and-moderate-aortic-stenosis/
https://gpcardio.org/en/2025-03-15_study-on-cardiovascular-risk-factors-and-primary-care-utilization-in-spain/
https://gpcardio.org/en/2025-03-16_primary-prevention-of-atherosclerotic-cardiovascular-disease-ascvd-in-primary-care-a-systematic-review-of-guidelines/
https://gpcardio.org/en/2025-03-17_sex-differences-and-trends-in-cardiovascular-risk-management-insights-from-a-long-term-primary-care-study/
https://gpcardio.org/en/2025-03-27_intensive-blood-pressure-control-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2025-03-28_flecainide-acetate-inhalation-solution-for-cardioversion-of-recent-onset-symptomatic-atrial-fibrillation/
https://gpcardio.org/en/2025-04-03_left-atrial-appendage-closure-after-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2025-04-10_dapagliflozin-in-patients-undergoing-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2025-04-10_introducing-gpcardio-bridging-the-gap-in-cardiovascular-care/
https://gpcardio.org/en/2025-04-17_pulsed-field-or-cryoballoon-ablation-for-paroxysmal-atrial-fibrillation/
https://gpcardio.org/en/2025-05-08_lorundrostat-efficacy-and-safety-in-patients-with-uncontrolled-hypertension/
https://gpcardio.org/en/2025-05-17_fixed-dose-combination-of-obicetrapib-and-ezetimibe-for-ldl-cholesterol-reduction-tandem/
https://gpcardio.org/en/2025-05-29_oral-semaglutide-and-cardiovascular-outcomes-in-high-risk-type-2-diabetes/
https://gpcardio.org/en/2025-06-03_an-oral-pcsk9-inhibitor-for-treatment-of-hypercholesterolemia/
https://gpcardio.org/en/2025-06-10_2025-acc-aha-acep-naemsp-scai-guideline-for-the-management-of-patients-with-acute-coronary-syndromes/
https://gpcardio.org/en/2025-06-10_intravenous-ferric-carboxymaltose-in-heart-failure-with-iron-deficiency/
https://gpcardio.org/en/2025-06-17_antihypertensive-medication-timing-and-cardiovascular-events-and-death/
https://gpcardio.org/en/2025-06-17_spironolactone-vs-amiloride-for-resistant-hypertension/
https://gpcardio.org/en/2025-07-01_add-on-treatment-with-zilebesiran-for-inadequately-controlled-hypertension/
https://gpcardio.org/en/2025-07-01_gpcardio-epccs-joins-each-in-european-alliance-for-cardiovascular-health/
https://gpcardio.org/en/2025-07-03_safety-and-efficacy-of-obicetrapib-in-patients-at-high-cardiovascular-risk/
https://gpcardio.org/en/2025-07-07_colchicine-for-secondary-prevention-of-vascular-events/
https://gpcardio.org/en/2025-07-07_long-term-trials-of-colchicine-for-secondary-prevention-of-vascular-events/
https://gpcardio.org/en/2025-07-08_catheter-ablation-vs-lifestyle-modification-with-antiarrhythmic-drugs-to-treat-atrial-fibrillation/
https://gpcardio.org/en/2025-07-10_gpcardio-and-acc-s-ncd-academy-join-forces-to-strengthen-primary-care-in-cardiovascular-disease-prevention/
https://gpcardio.org/en/2025-07-12_amycretin-a-novel-unimolecular-glp-1-and-amylin-receptor-agonist-administered-subcutaneously/
https://gpcardio.org/en/2025-07-12_safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-the-first-in-class-glp-1-and-amylin-receptor-agonist-amycretin/
https://gpcardio.org/en/2025-07-15_10-year-outcome-of-complete-or-infarct-artery-only-revascularization-in-stemi-with-multivessel-disease/
https://gpcardio.org/en/2025-07-22_cooperative-pfa/
https://gpcardio.org/en/2025-07-28_long-term-benefits-of-atorvastatin-on-the-incidence-of-cardiovascular-events/
https://gpcardio.org/en/2025-07-29_cvd-primary-care-the-need-for-epccs-practice-guidance/
https://gpcardio.org/en/2025-08-05_lorundrostat-in-participants-with-uncontrolled-hypertension-and-treatment-resistant-hypertension/
https://gpcardio.org/en/2025-08-14_coadministered-cagrilintide-and-semaglutide-in-adults-with-overweight-or-obesity/
https://gpcardio.org/en/2025-08-21_preventive-percutaneous-coronary-intervention-for-non-flow-limiting-vulnerable-atherosclerotic-coronary-plaques-in-diabetes/
https://gpcardio.org/en/2025-08-30_blood-pressure-lowering-efficacy-of-antihypertensive-drugs-and-their-combinations/
https://gpcardio.org/en/2025-09-01_conduction-system-pacing-vs-biventricular-pacing-for-cardiac-resynchronization/
https://gpcardio.org/en/2025-09-02_remote-atrial-fibrillation-screening-in-primary-care-using-an-ecg-patch-demonstrates-modest-benefits/
https://gpcardio.org/en/2025-09-05_blood-pressure-reductions-with-baxdrostat-in-patients-with-uncontrolled-or-resistant-hypertension/
https://gpcardio.org/en/2025-09-11_multidomain-rehabilitation-for-older-patients-with-myocardial-infarction/
https://gpcardio.org/en/2025-09-11_new-guidance-recommends-a-new-approach-to-assess-cardiovascular-risk-and-reach-treatment-goals-for-lipid-levels/
https://gpcardio.org/en/2025-09-13_β-blockers-after-myocardial-infarction-with-mildly-reduced-ejection-fraction/
https://gpcardio.org/en/2025-09-16_2025-aha-acc-aanp-aapa-abc-accp-acpm-ags-ama-aspc-nma-pcna-sgim-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressur/
https://gpcardio.org/en/2025-09-16_tackling-the-enduring-cardiovascular-impact-of-covid-19-new-guidance-for-primary-care/
https://gpcardio.org/en/2025-09-18_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-in-early-type-2-diabetes/
https://gpcardio.org/en/2025-09-20_effect-of-evolocumab-on-saphenous-vein-graft-patency-after-coronary-artery-bypass-surgery-newton-cabg-cardiolink-5/
https://gpcardio.org/en/2025-09-21_introduction-and-the-impact-of-cmr-on-patients-and-health-systems/
https://gpcardio.org/en/2025-09-24_key-changes-in-clinical-guidance-for-blood-pressure-and-lipid-management/
https://gpcardio.org/en/2025-09-25_digitoxin-in-patients-with-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2025-09-28_why-it-s-important-to-recognise-manage-chronic-kidney-disease-ckd/
https://gpcardio.org/en/2025-10-01_no-evidence-supports-vitamins-or-supplements-for-lowering-ldl-cholesterol-and-reducing-cardiovascular-risk/
https://gpcardio.org/en/2025-10-07_impact-of-obicetrapib-on-major-adverse-cardiovascular-events-in-high-risk-patients/
https://gpcardio.org/en/2025-10-09_efficacy-and-safety-of-baxdrostat-in-uncontrolled-and-resistant-hypertension/
https://gpcardio.org/en/2025-10-14_long-term-anticoagulation-discontinuation-after-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2025-10-27_bridging-heart-and-stroke-awareness-stronger-together/
https://gpcardio.org/en/2025-10-27_transcatheter-or-surgical-aortic-valve-replacement-in-low-risk-patients-at-7-years/
https://gpcardio.org/en/2025-10-28_effect-of-intensive-blood-pressure-control-on-stroke/
https://gpcardio.org/en/2025-10-28_immediate-or-deferred-nonculprit-lesion-pci-in-myocardial-infarction/
https://gpcardio.org/en/2025-10-28_intensive-blood-pressure-control-in-older-patients-with-hypertension/
https://gpcardio.org/en/2025-11-04_2025-aha-acc-aanp-aapa-abc-accp-acpm-ags-ama-aspc-nma-pcna-sgim-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressur/
https://gpcardio.org/en/2025-11-06_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-for-obesity-treatment/
https://gpcardio.org/en/2025-11-09_pcsk9-inhibitor-prevents-first-heart-attack-or-stroke-in-high-risk-patients/
https://gpcardio.org/en/2025-11-10_high-dose-vs-standard-dose-influenza-vaccine-and-cardiovascular-outcomes-in-older-adults/
https://gpcardio.org/en/2025-11-11_decaf-a-cup-of-coffee-a-day-could-keep-atrial-fibrillation-from-coming-back/
https://gpcardio.org/en/2025-11-13_beta-blockers-after-myocardial-infarction-in-patients-without-heart-failure/
https://gpcardio.org/en/2025-11-13_beta-blockers-after-myocardial-infarction-without-reduced-ejection-fraction/
https://gpcardio.org/en/2025-11-18_2025-acc-scientific-statement-on-the-management-of-obesity-in-adults-with-heart-failure/
https://gpcardio.org/en/2025-11-18_dapagliflozin-in-patients-hospitalized-for-heart-failure/
https://gpcardio.org/en/2025-11-21_epccs-council-launches-gpcardio-as-a-commitment-to-support-primary-care/
https://gpcardio.org/en/2025-12-13_complete-versus-culprit-lesion-only-revascularisation-for-acute-myocardial-infarction-complete-revascularisation-trialists-collaboration/
https://gpcardio.org/en/2025-12-16_long-term-effect-of-icds-in-nonischemic-heart-failure-with-reduced-ejection-fraction/
https://gpcardio.org/en/2025-12-18_2025-acc-aha-hrs-isachd-scai-guideline-for-the-management-of-adults-with-congenital-heart-disease/
https://gpcardio.org/en/2025-12-18_improve-dice-a-2-part-open-label-phase-2a-trial-evaluating-the-safety-and-effectiveness-of-ninerafaxstat-in-patients-with-cardiometabolic-syndromes/
https://gpcardio.org/en/2025-12-19_eu-launches-ambitious-safe-hearts-plan-a-new-roadmap-in-cardiovascular-health/
https://gpcardio.org/en/2025-12-20_orforglipron-an-oral-small-molecule-glp-1-receptor-agonist-for-the-treatment-of-obesity-in-people-with-type-2-diabetes-attain-2/
https://gpcardio.org/en/2026-01-06_global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity-issued-by-who/
https://gpcardio.org/en/2026-01-07_cxcr6-t-cells-drive-immune-checkpoint-inhibitor-myocarditis/
https://gpcardio.org/en/2026-01-10_nicotine-and-the-cardiovascular-system-key-insights-for-primary-care/
https://gpcardio.org/en/2026-01-13_efficacy-and-safety-of-oral-pcsk9-inhibitor-enlicitide-in-adults-with-heterozygous-familial-hypercholesterolemia/
https://gpcardio.org/en/2026-01-14_glucagon-like-receptor-agonists-and-next-generation-incretin-based-medications/
https://gpcardio.org/en/2026-01-15_socioeconomic-and-structural-barriers-to-addressing-obesity-in-communities/
https://gpcardio.org/en/2026-01-19_stroke-identified-as-the-second-leading-cause-of-death-from-cardiovascular-disease-and-a-major-contributor-of-acquired-long-term-disability/
https://gpcardio.org/en/2026-01-20_environmental-stressors-and-cardiovascular-health/
https://gpcardio.org/en/2026-01-20_sglt2-inhibitors-and-kidney-outcomes-by-glomerular-filtration-rate-and-albuminuria/
https://gpcardio.org/en/2026-01-20_triple-versus-dual-lipid-lowering-therapy-in-acute-coronary-syndrome/
https://gpcardio.org/en/2026-01-21_2026-heart-disease-and-stroke-statistics/
https://gpcardio.org/en/2026-01-22_antithrombotic-therapy-after-successful-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-01-27_colchicine-in-acute-coronary-syndromes/
https://gpcardio.org/en/2026-01-27_potent-p2y12-inhibitor-monotherapy-vs-dapt-after-pci-in-patients-with-and-without-stemi/
https://gpcardio.org/en/2026-01-29_olezarsen-for-managing-severe-hypertriglyceridemia-and-pancreatitis-risk/
https://gpcardio.org/en/2026-01-30_systemic-embolic-events-in-atrial-fibrillation/
https://gpcardio.org/en/2026-02-01_semaglutide-and-hospitalizations-in-patients-with-obesity-and-established-cardiovascular-disease/
https://gpcardio.org/en/2026-02-01_β-blockers-after-myocardial-infarction-in-patients-with-preserved-ejection-fraction/
https://gpcardio.org/en/2026-02-03_dapagliflozin-to-reduce-early-recurrence-after-catheter-ablation-for-atrial-fibrillation/
https://gpcardio.org/en/2026-02-04_ai-digital-stethoscopes-outperform-traditional-screening-for-significant-vhd/
https://gpcardio.org/en/2026-02-05_efimosfermin-alfa-bos-580-once-per-month-in-people-with-metabolic-dysfunction-associated-steatohepatitis-with-f2-or-f3-fibrosis/
https://gpcardio.org/en/2026-02-05_intravenous-tenecteplase-for-acute-ischaemic-stroke-within-24-h-due-to-basilar-artery-occlusion/
https://gpcardio.org/en/2026-02-05_tenecteplase-versus-standard-medical-treatment-for-basilar-artery-occlusion-within-24-h-trace-5/
https://gpcardio.org/en/2026-02-06_talking-to-patients-about-statins-why-most-reported-symptoms-aren-t-causal/
https://gpcardio.org/en/2026-02-09_coronary-atherosclerosis-in-patients-with-cancer-and-survivors/
https://gpcardio.org/en/2026-02-10_clonal-hematopoiesis-and-its-cardiovascular-implications/
https://gpcardio.org/en/2026-02-10_new-drug-therapies-for-hypertension/
https://gpcardio.org/en/2026-02-10_spontaneous-myocardial-infarction-after-left-main-revascularization/
https://gpcardio.org/en/2026-02-10_transthyretin-cardiac-amyloidosis-evaluation-and-management/
https://gpcardio.org/en/2026-02-11_criteria-to-assess-the-predictive-and-clinical-utility-of-novel-models-biomarkers-and-tools-for-risk-of-cardiovascular-disease/
https://gpcardio.org/en/2026-02-11_vericiguat-and-mortality-in-heart-failure-and-reduced-ejection-fraction/
https://gpcardio.org/en/2026-02-18_beta-blockers-after-myocardial-infarction/
https://gpcardio.org/en/2026-02-18_gene-therapy-for-nephropathic-cystinosis/
https://gpcardio.org/en/2026-02-19_2026-aha-acc-accp-acep-chest-scai-shm-sir-svm-svn-guideline-for-the-evaluation-and-management-of-acute-pulmonary-embolism-in-adults/
https://gpcardio.org/en/2026-02-19_conduction-disturbances-after-transcatheter-aortic-valve-implantation/
https://gpcardio.org/en/2026-02-19_secondary-prevention-after-ischemic-stroke/
https://gpcardio.org/en/2026-02-19_transcatheter-or-surgical-aortic-valve-replacement-in-low-risk-patients-at-7-years/
https://gpcardio.org/en/2026-02-21_pelacarsen-and-lipoprotein-a-apheresis-in-secondary-prevention/
https://gpcardio.org/en/2026-02-23_immunoadsorption-in-dilated-cardiomyopathy/
https://gpcardio.org/en/2026-02-23_the-year-in-cardiovascular-medicine-2025/
https://gpcardio.org/en/2026-02-24_malnutrition-and-cachexia-in-inpatients-with-acute-cardiac-conditions/
https://gpcardio.org/en/2026-02-24_risk-of-heart-failure-hospitalization-for-glp-1-receptor-agonists-versus-dpp-4-inhibitors-or-sglt-2-inhibitors-in-patients-with-type-2-diabetes/
https://gpcardio.org/en/2026-02-25_combined-associations-of-glp-1-receptor-agonists-and-a-healthy-lifestyle-with-cardiovascular-outcomes-among-individuals-with-type-2-diabetes/
https://gpcardio.org/en/2026-02-25_forecasting-the-burden-of-cardiovascular-disease-and-stroke-in-women-in-the-united-states-through-2050/
https://gpcardio.org/en/2026-02-25_outcomes-of-heart-failure-with-reduced-mildly-reduced-or-preserved-ejection-fraction/
https://gpcardio.org/en/2026-02-27_carotid-plaque-macrophage-burden-and-inflammatory-lipid-associated-macrophage-markers-predict-secondary-major-adverse-cardiovascular-events-after-enda/
https://gpcardio.org/en/2026-02-27_sglt2-inhibition-in-patients-with-type-2-diabetes-and-ckd-experiencing-a-deterioration-in-estimated-glomerular-filtration-rate-to-20ml-min-1-73m/
https://gpcardio.org/en/2026-02-27_switching-from-warfarin-to-direct-oral-anticoagulants-in-frail-elderly-asian-patients-with-atrial-fibrillation/
https://gpcardio.org/en/2026-02-28_heart-failure-in-the-elderly/
https://gpcardio.org/en/2026-03-02_nighttime-road-traffic-noise-stresses-the-heart-and-blood-vessels/
https://gpcardio.org/en/2026-03-04_aspirin-after-pci-in-acute-coronary-syndromes/
https://gpcardio.org/en/2026-03-04_blood-pressure-targets-in-hypertension-management/
https://gpcardio.org/en/2026-03-05_finerenone-in-type-1-diabetes-and-chronic-kidney-disease/
https://gpcardio.org/en/2026-03-05_oral-pcsk9-inhibitor-enlicitide-lowers-ldl-cholesterol-levels-in-phase-2-trial/
https://gpcardio.org/en/2026-03-06_kidney-disease-and-heart-failure/
https://gpcardio.org/en/2026-03-07_atrial-fibrillation/
https://gpcardio.org/en/2026-03-07_effect-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-bax24/
https://gpcardio.org/en/2026-03-07_effect-of-baxdrostat-on-ambulatory-blood-pressure-in-patients-with-resistant-hypertension-bax24/
https://gpcardio.org/en/2026-03-09_targets-and-treatments-to-manage-ldl-c-in-primary-care/
https://gpcardio.org/en/2026-03-10_genetic-screening-for-fh-rationale-and-experience/
https://gpcardio.org/en/2026-03-10_lp-a-time-to-start-measuring-in-primary-care/
https://gpcardio.org/en/2026-03-11_triglycerides-a-risk-marker-or-target-for-cv-risk/
https://gpcardio.org/en/2026-03-12_cardiovascular-metabolic-risk-in-menopause/
https://gpcardio.org/en/2026-03-12_esc-guidance-on-cvd-and-mental-health-in-primary-care/
https://gpcardio.org/en/2026-03-13_2026-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-the-management-of-dyslipidemia/
https://gpcardio.org/en/2026-03-13_heart-failure-in-primary-care-early-recognition-and-initiation-of-gdmt/
https://gpcardio.org/en/2026-03-13_managing-difficult-to-control-hypertension-and-what-s-new/
https://gpcardio.org/en/2026-03-13_the-need-for-gp-engagement-in-the-world-of-advocacy/
https://gpcardio.org/en/2026-03-14_the-pulse-of-primary-care-epccs-summit-2026/
https://gpcardio.org/en/2026-03-16_use-of-coronary-artery-calcium-scoring-in-individuals-with-elevated-lipoprotein-a/
https://gpcardio.org/en/2026-03-20_the-impact-of-epccs-guidance-on-pharmacotherapy-in-ukraine/
https://gpcardio.org/en/2026-03-22_cardiovascular-risk-management-in-poland/
https://gpcardio.org/en/2026-03-22_hypertension-guidelines-update-in-turkey/
https://gpcardio.org/en/2026-03-22_screening-for-cvd-in-greece/
https://gpcardio.org/en/2026-03-23_guideline-directed-medical-therapy-in-ckd-the-crucial-role-for-primary-care/
https://gpcardio.org/en/2026-03-24_managing-ckd-in-primary-care/
https://gpcardio.org/en/2026-03-24_screening-risk-stratification-in-ckd-the-crucial-role-for-primary-care/
https://gpcardio.org/en/2026-03-24_systemic-inflammation-and-recurrence-after-atrial-fibrillation-related-stroke/
https://gpcardio.org/en/about-epccs/
https://gpcardio.org/en/about-ipccs/
https://gpcardio.org/en/cvd-ckd-t2d/
https://gpcardio.org/en/each/
https://gpcardio.org/en/education/
https://gpcardio.org/en/education/cardio-renal-update/
https://gpcardio.org/en/education/cardiovascular-disease-in-special-populations/
https://gpcardio.org/en/education/cardiovascular-update-session-for-primary-care/
https://gpcardio.org/en/education/lipid-management-in-primary-care/
https://gpcardio.org/en/education/managing-cv-risk-in-europe-lessons-from-countries/
https://gpcardio.org/en/education/the-eu-cardiovascular-health-plan/
https://gpcardio.org/en/epccs/
https://gpcardio.org/en/epccs/connected-societies/
https://gpcardio.org/en/esc-congress-2025/
https://gpcardio.org/en/gpcardio/
https://gpcardio.org/en/literature/
https://gpcardio.org/en/ncd-academy/
https://gpcardio.org/en/resources/
https://gpcardio.org/en/resources/meeting-reports/
https://gpcardio.org/en/resources/practice-guidance/
https://gpcardio.org/en/resources/recent-news/
https://gpcardio.org/en/resources/stratifyhf/
https://gpcardio.org/en/resources/video-updates/
https://gpcardio.org/en/scan/
https://gpcardio.org/en/science-updates/
https://gpcardio.org/en/society-updates/
https://gpcardio.org/en/wonca-world-2025/